Again this frivolous nonsense about ECA. Did I tell you that Genentech's Avastin didn't extend OS for rGBM and FDA still granted approval since it reduced tumor size? We are living in molecular age. See the following figure? The data were from 29 patients in the p3 trial. These are the measurements of the genes currently adopted in precision medicine prior to the DCVax-L treatment. I only show a very few of all the genes since the total number of genes measured is over 17 thousand. It is commonsense that NWBO should collect the data for all those genes after the treatment just like what Dr. Liau did for the poly-iclc trial. I am confident experts from any RAs would marvel at what they saw.
I suggest you stop this nonsense discussion on ECA and find a new perspective.
Market Data 
Markets 
AI
